NRC Health Acquisitions, Net of Cash Acquired
NRC Health (NRC) reported Acquisitions, Net of Cash Acquired of $4.83 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2024-11-08
- NRC Health payments to acquire businesses, net of cash acquired for the quarter ending 2011-12-31 was $1.00K.
- NRC Health payments to acquire businesses, net of cash acquired for the quarter ending 2011-09-30 was $116.00K.
- NRC Health payments to acquire businesses, net of cash acquired for the quarter ending 2011-06-30 was $2.43M.
- NRC Health payments to acquire businesses, net of cash acquired for the quarter ending 2011-03-31 was $1.56M.
- NRC Health payments to acquire businesses, net of cash acquired for fiscal 2014 was $2.57M.
- NRC Health payments to acquire businesses, net of cash acquired for fiscal 2011 was $4.12M, a 73.35% decline from fiscal 2010.
- NRC Health payments to acquire businesses, net of cash acquired for fiscal 2010 was $15.44M, a 16503.23% increase from fiscal 2009.
- NRC Health payments to acquire businesses, net of cash acquired for fiscal 2009 was $93.00K.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2024-09-30 | $4.83M 10-Q · filed 2024-11-08 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | |||
| 2014-12-31 | $2.57M 10-K · filed 2017-03-03 | |||
| 2011-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $117.00K derived: sum of 2 quarters · filed 2014-03-04 | $2.55M derived: sum of 3 quarters · filed 2014-03-04 | $4.12M 10-K · filed 2014-03-04 |
| 2011-09-30 | $116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $2.55M derived: sum of 2 quarters · filed 2012-11-07 | $4.11M 10-Q · filed 2012-11-07 | $4.11M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $4.00M 10-Q · filed 2012-08-10 | $4.00M derived: sum of 3 quarters · filed 2013-03-01 | |
| 2011-03-31 | $1.56M 10-Q · filed 2012-05-11 | $1.56M derived: sum of 2 quarters · filed 2013-03-01 | ||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $15.44M 10-K · filed 2013-03-01 | ||
| 2010-09-30 | $15.44M 10-Q · filed 2011-11-08 | |||
| 2009-12-31 | $93.00K 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |